Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing.
Loeb S, Cheng HH, Leader A, Gross L, Nolasco TS, Byrne N, Wise DR, Hollifield L, Brown LH, Slater E, Pieczonka C, Gomella LG, Kelly WK, Trabulsi EJ, Handley N, Lallas CD, Chandrasekar T, Mille P, Mann M, Mark JR, Brown G, Chopra S, Wasserman J, Phillips J, Somers P, Giri VN. Loeb S, et al. Among authors: nolasco ts. Contemp Clin Trials. 2022 Aug;119:106821. doi: 10.1016/j.cct.2022.106821. Epub 2022 Jun 14. Contemp Clin Trials. 2022. PMID: 35710085 Clinical Trial.
Sleep disturbances are underappreciated in prostate cancer survivorship.
Gong F, Loeb S, Siu K, Myrie A, Orstad S, Kenfield SA, Morgans A, Thakker S, Robbins R, Carter P, Jean-Louis G, Nolasco TS, Byrne N, Gupta N. Gong F, et al. Among authors: nolasco ts. Prostate Cancer Prostatic Dis. 2023 Mar;26(1):210-212. doi: 10.1038/s41391-022-00630-6. Epub 2022 Dec 21. Prostate Cancer Prostatic Dis. 2023. PMID: 36543892